Comparisons of Immunoassay and Mass Spectrometry Measurements of Serum Estradiol Levels and Their Influence on Clinical Association Studies in Men
Author(s) -
Claes Ohlsson,
Maria Nilsson,
Åsa Tivesten,
Henrik Ryberg,
Dan Mellström,
Magnus K. Karlsson,
Östen Ljunggren,
Fernand Labrie,
Eric Orwoll,
David M. Lee,
Stephen R. Pye,
Terence W O’Neill,
Joseph D. Finn,
Judith E. Adams,
Kate A. Ward,
Steven Boonen,
György Bártfai,
Felipe F. Casanueva,
Gianni Forti,
Aleksander Giwercman,
Thang S. Han,
Ilpo Huhtaniemi,
Krzysztof Kula,
Michael E. J. Lean,
Neil Pendleton,
Margus Punab,
Dirk Vanderschueren,
Frederick C. W. Wu,
Liesbeth Vandenput
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-3861
Subject(s) - immunoassay , medicine , radioimmunoassay , body mass index , context (archaeology) , osteoporosis , chemiluminescent immunoassay , endocrinology , immunology , antibody , biology , paleontology
Immunoassay-based techniques, routinely used to measure serum estradiol (E2), are known to have reduced specificity, especially at lower concentrations, when compared with the gold standard technique of mass spectrometry (MS). Different measurement techniques may be responsible for the conflicting results of associations between serum E2 and clinical phenotypes in men.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom